AMAmneal Pharmaceuticals AMRX · NASDAQ
$19.36 +0.94% (+$0.18)
- Market cap
- $6.18B
- Enterprise value
- $8.85B
- P/E
- 39.3x
- Forward P/E
- 18.5x
- PEG
- -
- P/S
- 2.0x
- P/FCF
- 74.4x
- EV/EBITDA
- 13.6x
- ROIC
- 14.3%
- Bruto marža
- 39.3%
- Neto marža
- 5.0%
- Dividend yield
- -
- Payout ratio
- -
- Neto dolg/EBITDA
- 4.1x
- Beta
- 1.22
- Free float
- 45.0%
O podjetju
Amneal Pharmaceuticals, Inc. is an American pharmaceutical company focused on the development, manufacturing, and distribution of generic and specialty medications. The company specializes in a broad range of therapeutic areas, including cardiovascular diseases, neurological disorders, oncology, and more. Amneal also produces its own branded products targeting specific conditions. The company is known for its ability to provide affordable medications while continuing to develop innovative therapies.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Chirag K. Patel
Employees
8,700
Headquarters
Bridgewater
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke